<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Patient Health Record</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Mr. HUMBERTO CIANCI</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">August 21, 1954 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Available</li><li>Other Race</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>600 W LAS OLAS BLVD<br/>APT 1604F<br/>FORT LAUDERDALE, FL 33312-7165, US<br/><br/>Primary Home Phone:  954-258-3429<br/>Email:  HUMBERTO.CIANCI@GMAIL.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">459835 2.16.840.1.113883.4.391.327187<br/>459835 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">99302e80-63fc-4f7a-879b-89ac9697b992 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">September 20, 2024, 13:25:06 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Dana Mehra, ARNP</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Jarrod Frydman</td></tr><tr><td class="td_header_role_value internal_format">350 N PINE ISLAND RD<br/>STE 302<br/>PLANTATION, FL 33324-1849, US<br/><br/>Tel:  954-581-8272<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">HUMBERTO CIANCI<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  954-258-3429<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">moxifloxacin</td><td>Avelox</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td>08/21/2013</td><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</span><br/>Reviewed date:07/19/2024 06:18:40 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; FASTING; NON-FASTING<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">CHOLESTEROL, TOTAL</td><td>133</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result1_attr2">HDL CHOLESTEROL</td><td>41</td><td>&gt; OR = 40 mg/dL</td><td/></tr><tr><td ID="result1_attr3">TRIGLYCERIDES</td><td>125</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result1_attr4">LDL-CHOLESTEROL</td><td>71</td><td/><td ID="result1_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the Martin-Hopkins</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>Martin SS et al. JAMA. 2013;310(19): 2061-2068</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p></td></tr><tr><td ID="result1_attr5">CHOL/HDLC RATIO</td><td>3.2</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result1_attr6">NON HDL CHOLESTEROL</td><td>92</td><td>&lt;130 mg/dL (calc)</td><td ID="result1_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>option.</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:07/19/2024 06:18:50 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; FASTING; NON-FASTING<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result2_attr1">GLUCOSE</td><td>93</td><td>65-99 mg/dL</td><td ID="result2_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result2_attr2">UREA NITROGEN (BUN)</td><td>17</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result2_attr3">CREATININE</td><td>1.02</td><td>0.70-1.35 mg/dL</td><td/></tr><tr><td ID="result2_attr4">EGFR</td><td>80</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result2_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result2_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result2_attr6">SODIUM</td><td>140</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result2_attr7">POTASSIUM</td><td>4.3</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result2_attr8">CHLORIDE</td><td>104</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result2_attr9">CARBON DIOXIDE</td><td>29</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result2_attr10">CALCIUM</td><td>9.3</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result2_attr11">PROTEIN, TOTAL</td><td>6.5</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result2_attr12">ALBUMIN</td><td>4.3</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result2_attr13">GLOBULIN</td><td>2.2</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result2_attr14">ALBUMIN/GLOBULIN RATIO</td><td>2.0</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result2_attr15">BILIRUBIN, TOTAL</td><td>0.9</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result2_attr16">ALKALINE PHOSPHATASE</td><td>55</td><td>35-144 U/L</td><td/></tr><tr><td ID="result2_attr17">AST</td><td>17</td><td>10-35 U/L</td><td/></tr><tr><td ID="result2_attr18">ALT</td><td>19</td><td>9-46 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CREATINE KINASE, TOTAL (374)</span><br/>Reviewed date:07/19/2024 06:18:53 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; FASTING; NON-FASTING<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result3_attr1">CREATINE KINASE, TOTAL</td><td>71</td><td>44-196 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">PSA, TOTAL (5363)</span><br/>Reviewed date:04/16/2024 01:33:54 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>FASTING; NON-FASTING; NON-FASTING; NON-FASTING</td></tr><tr><td ID="result4_attr1">PSA, TOTAL</td><td>4.88</td><td>&lt; OR = 4.00 ng/mL</td><td ID="result4_attr1_notes"><p>The total PSA value from this assay system is</p><p>standardized against the WHO standard. The test</p><p>result will be approximately 20% lower when compared</p><p>to the equimolar-standardized total PSA (Beckman</p><p>Coulter). Comparison of serial PSA results should be</p><p>interpreted with this fact in mind.</p><p>This test was performed using the Siemens</p><p>chemiluminescent method. Values obtained from</p><p>different assay methods cannot be used</p><p>interchangeably. PSA levels, regardless of</p><p>value, should not be interpreted as absolute</p><p>evidence of the presence or absence of disease.</p></td></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:04/16/2024 01:34:08 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>FASTING; NON-FASTING; NON-FASTING; NON-FASTING</td></tr><tr><td ID="result5_attr1">WHITE BLOOD CELL COUNT</td><td>6.8</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result5_attr2">RED BLOOD CELL COUNT</td><td>4.87</td><td>4.20-5.80 Million/uL</td><td/></tr><tr><td ID="result5_attr3">HEMOGLOBIN</td><td>14.8</td><td>13.2-17.1 g/dL</td><td/></tr><tr><td ID="result5_attr4">HEMATOCRIT</td><td>43.5</td><td>38.5-50.0 %</td><td/></tr><tr><td ID="result5_attr5">MCV</td><td>89.3</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result5_attr6">MCH</td><td>30.4</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result5_attr7">MCHC</td><td>34.0</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result5_attr8">RDW</td><td>12.8</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result5_attr9">PLATELET COUNT</td><td>229</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result5_attr10">MPV</td><td>10.5</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result5_attr11">ABSOLUTE NEUTROPHILS</td><td>3434</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result5_attr12">ABSOLUTE LYMPHOCYTES</td><td>2509</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result5_attr13">ABSOLUTE MONOCYTES</td><td>707</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result5_attr14">ABSOLUTE EOSINOPHILS</td><td>102</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result5_attr15">ABSOLUTE BASOPHILS</td><td>48</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result5_attr16">NEUTROPHILS</td><td>50.5</td><td/><td/></tr><tr><td ID="result5_attr17">LYMPHOCYTES</td><td>36.9</td><td/><td/></tr><tr><td ID="result5_attr18">MONOCYTES</td><td>10.4</td><td/><td/></tr><tr><td ID="result5_attr19">EOSINOPHILS</td><td>1.5</td><td/><td/></tr><tr><td ID="result5_attr20">BASOPHILS</td><td>0.7</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</span><br/>Reviewed date:04/16/2024 01:34:11 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>FASTING; NON-FASTING; NON-FASTING; NON-FASTING</td></tr><tr><td ID="result6_attr1">CHOLESTEROL, TOTAL</td><td>124</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result6_attr2">HDL CHOLESTEROL</td><td>43</td><td>&gt; OR = 40 mg/dL</td><td/></tr><tr><td ID="result6_attr3">TRIGLYCERIDES</td><td>96</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result6_attr4">LDL-CHOLESTEROL</td><td>63</td><td/><td ID="result6_attr4_notes"><p>Reference range: &lt;100</p><p>LDL-C is now calculated using the Martin-Hopkins</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>Martin SS et al. JAMA. 2013;310(19): 2061-2068</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p><p>with &gt; or = 2 CHD risk factors.</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p></td></tr><tr><td ID="result6_attr5">CHOL/HDLC RATIO</td><td>2.9</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result6_attr6">NON HDL CHOLESTEROL</td><td>81</td><td>&lt;130 mg/dL (calc)</td><td ID="result6_attr6_notes"><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p><p>For patients with diabetes plus 1 major ASCVD risk</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:04/16/2024 01:34:16 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
10200 Commerce Pkwy, Miramar
FL
33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>FASTING; NON-FASTING; NON-FASTING; NON-FASTING</td></tr><tr><td ID="result7_attr1">GLUCOSE</td><td>91</td><td>65-99 mg/dL</td><td ID="result7_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result7_attr2">UREA NITROGEN (BUN)</td><td>15</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result7_attr3">CREATININE</td><td>0.99</td><td>0.70-1.35 mg/dL</td><td/></tr><tr><td ID="result7_attr4">EGFR</td><td>82</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result7_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result7_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result7_attr6">SODIUM</td><td>141</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result7_attr7">POTASSIUM</td><td>4.5</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result7_attr8">CHLORIDE</td><td>104</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result7_attr9">CARBON DIOXIDE</td><td>29</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result7_attr10">CALCIUM</td><td>9.1</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result7_attr11">PROTEIN, TOTAL</td><td>6.5</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result7_attr12">ALBUMIN</td><td>4.3</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result7_attr13">GLOBULIN</td><td>2.2</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result7_attr14">ALBUMIN/GLOBULIN RATIO</td><td>2.0</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result7_attr15">BILIRUBIN, TOTAL</td><td>0.6</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result7_attr16">ALKALINE PHOSPHATASE</td><td>73</td><td>35-144 U/L</td><td/></tr><tr><td ID="result7_attr17">AST</td><td>28</td><td>10-35 U/L</td><td/></tr><tr><td ID="result7_attr18">ALT</td><td>26</td><td>9-46 U/L</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div>No Information</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Sinemet 25-100 MG</td><td ID="instruction1">1 tablet Orally TWICE DAILY</td><td/><td>04/18/2024</td><td/><td>Active</td></tr><tr><td ID="medication2">Saw Palmetto -</td><td ID="instruction2">as directed Orally QD</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Flax Seed Oil 1000 MG</td><td ID="instruction3">as directed Orally QD</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Montelukast Sodium 10 MG</td><td ID="instruction4">1 tablet Orally Once a day PRN for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Metoprolol Tartrate 25 MG</td><td ID="instruction5">Take 1 tablet by mouth once daily with food for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Centrum Adults -</td><td ID="instruction6">as directed Orally</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Aspirin 81 MG</td><td ID="instruction7">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Flonase Allergy Relief 50 MCG/ACT</td><td ID="instruction8">1 spray in each nostril Nasally Once a day PRN</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Rosuvastatin Calcium 5 MG</td><td ID="instruction9">1 tablet Orally Once a day for 90 days</td><td/><td>07/25/2024</td><td/><td>Active</td></tr><tr><td ID="medication10">CoQ-10 100 MG</td><td ID="instruction10"><p>as directed Orally ONCE A DAY</p><p>As needed</p></td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Loratadine Allergy Relief</td><td ID="instruction11"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Metamucil 48.57 %</td><td ID="instruction12">as directed Orally PRN</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">Influenza (split), 3 yrs and above</td><td>Unknown</td><td>10/06/2021</td><td>Administered</td><td ID="immunization1notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization2">Influenza, quadrivalent, split, preservative free, 3 years or older</td><td>Unknown</td><td>09/08/2022</td><td>Administered</td><td ID="immunization2notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization3">Pfizer-Biontech Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>01/05/2021</td><td>History of Immunity</td><td ID="immunization3notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization4">Pfizer-Biontech Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>01/26/2021</td><td>History of Immunity</td><td ID="immunization4notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization5">Pfizer-Biontech Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>09/07/2021</td><td>Administered</td><td ID="immunization5notes">  Immunization Given by from source eCW:: </td></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Anxiety disorder (197480006)</td><td ID="Problem1">Anxiety disorder, unspecified (F41.9)</td><td>08/21/2013</td><td>Active</td><td>confirmed</td><td/><td ID="problems1notes">RELAXATION TECHNIQUES DISCUSSED. RARE USE OF XANAX PRN</td></tr><tr><td>Problem</td><td>Allergic rhinitis due to pollen (21719001)</td><td ID="Problem2">Allergic rhinitis due to pollen (J30.1)</td><td>03/14/2018</td><td>Active</td><td>confirmed</td><td/><td ID="problems2notes">CONT MONTELUKAST DAILY.    FLONASE AND LORATIDINE DAILY PRN.</td></tr><tr><td>Problem</td><td>Gastro-esophageal reflux disease without esophagitis (266435005)</td><td ID="Problem3">Gastro-esophageal reflux disease without esophagitis (K21.9)</td><td>11/16/2015</td><td>Active</td><td>confirmed</td><td/><td ID="problems3notes">GERD DIET. OMEPRAZOLE PRN</td></tr><tr><td>Problem</td><td>Chronic kidney disease stage 2 (431856006)</td><td ID="Problem4">Chronic kidney disease, stage 2 (mild) (N18.2)</td><td>01/04/2021</td><td>Active</td><td>confirmed</td><td/><td ID="problems4notes">AVOID NEPHROTOXINS. MAINTAIN ADEQUATE HYDRATION</td></tr><tr><td>Problem</td><td>Overactive bladder (786457000)</td><td ID="Problem5">Overactive bladder (N32.81)</td><td>04/03/2019</td><td>Active</td><td>confirmed</td><td/><td ID="problems5notes">SEEN BY URO DR. MARKS. DECLINES MEDS</td></tr><tr><td>Problem</td><td>Aortic valve disorder (8722008)</td><td ID="Problem6">Nonrheumatic aortic (valve) insufficiency (I35.1)</td><td>12/01/2015</td><td>Active</td><td>confirmed</td><td/><td ID="problems6notes">MONITORED BY DR. CUSNIR- CARDIO</td></tr><tr><td>Problem</td><td>Hyperlipidemia (55822004)</td><td ID="Problem7">Hyperlipidemia, unspecified (E78.5)</td><td>08/21/2013</td><td>Active</td><td>confirmed</td><td/><td ID="problems7notes">CHANGE ATORVASTATIN----------&gt;  ROSUVASTATIN 5 MG QHS, 2/2 MYALGIAS.   STOP FISH OIL.   LOW CHOL AND FAT DIET.  GOAL LDL &lt;130.</td></tr><tr><td>Problem</td><td>Chronic kidney disease due to hypertension (104931000119100)</td><td ID="Problem8">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (I12.9)</td><td>01/04/2021</td><td>Active</td><td>confirmed</td><td/><td ID="problems8notes">DASH DIET. MAINTAIN BP LESS THAN 145/85.</td></tr><tr><td>Problem</td><td>Lower urinary tract symptoms due to benign prostatic hypertrophy (30041000119101)</td><td ID="Problem9">Benign prostatic hyperplasia with lower urinary tract symptoms (N40.1)</td><td>07/27/2018</td><td>Active</td><td>confirmed</td><td/><td ID="problems9notes">FOLLOWED BY URO DR. MARKS. BENIGN BREAST BIOPSY --11/2020</td></tr><tr><td>Problem</td><td>Benign paroxysmal positional vertigo (111541001)</td><td ID="Problem10">Benign paroxysmal vertigo, bilateral (H81.13)</td><td>04/08/2020</td><td>Inactive</td><td>confirmed</td><td/><td ID="problems10notes">RX MECLIZINE. WILL GET NEW REF FOR ENT. GIVEN HOME EXERCISES TO DO. SLOW POSITION CHANGES</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>54 /min</td><td>07/25/2024</td><td ID="vital1notes">LOSE 1LB</td></tr><tr><th ID="vital2">Temperature</th><td>98.2 degrees Fahrenheit</td><td>07/25/2024</td><td ID="vital2notes">LOSE 1LB</td></tr><tr><th ID="vital3">Respiratory Rate</th><td>16 /min</td><td>07/25/2024</td><td ID="vital3notes">LOSE 1LB</td></tr><tr><th ID="vital4">Blood pressure diastolic</th><td>76 mm Hg</td><td>07/25/2024</td><td ID="vital4notes">LOSE 1LB</td></tr><tr><th ID="vital5">Oximetry</th><td>98 %</td><td>07/25/2024</td><td ID="vital5notes">LOSE 1LB</td></tr><tr><th ID="vital6">Height-cm</th><td>187.96 cm</td><td>07/25/2024</td><td ID="vital6notes">LOSE 1LB</td></tr><tr><th ID="vital7">Weight-kg</th><td>88.45 kg</td><td>07/25/2024</td><td ID="vital7notes">LOSE 1LB</td></tr><tr><th ID="vital8">Height</th><td>74 in</td><td>07/25/2024</td><td ID="vital8notes">LOSE 1LB</td></tr><tr><th ID="vital9">Blood pressure systolic</th><td>112 mm Hg</td><td>07/25/2024</td><td ID="vital9notes">LOSE 1LB</td></tr><tr><th ID="vital10">Weight</th><td>195 lbs</td><td>07/25/2024</td><td ID="vital10notes">LOSE 1LB</td></tr><tr><th ID="vital11">BMI</th><td>25.03 kg/m2</td><td>07/25/2024</td><td ID="vital11notes">LOSE 1LB</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">HEDIS: Blood Pressure Diastolic Less than 80</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure2">HEDIS: Blood Pressure Systolic &lt; 130</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure3">HEDIS: COA Functional Status</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure4">HEDIS: COA Medication Review</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure5">HEDIS: COA Pain Not Present</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure6">HEDIS: Depression Screening (If completed)</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure7">HEDIS: Fall Risk (If completed)</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure8">HEDIS: Tobacco Non-User</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure9">HEDIS: Advanced Care Planning</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure10">HEDIS: BMI 22 - 30</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure11">HEDIS: Depression Screening - Negative</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure12">HEDIS: Fall Risk - No Falls or 1 fall</td><td>04/18/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure13">HEDIS: COA Medication Review</td><td>07/25/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure14">HEDIS: Blood Pressure Systolic &lt; 130</td><td>07/25/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure15">HEDIS: Blood Pressure Diastolic Less than 80</td><td>07/25/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure16">HEDIS: Tobacco Non-User</td><td>07/25/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure17">HEDIS: BMI 22 - 30</td><td>07/25/2024</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>11/27/2023</td><td>Dana Mehra</td><td/></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>12/18/2023</td><td>Dana Mehra</td><td/></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>03/12/2024</td><td>Jarrod Frydman</td><td/></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>04/18/2024</td><td>Dana Mehra</td><td/></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>05/08/2024</td><td>Jarrod Frydman</td><td/></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>08/12/2024</td><td>Jarrod Frydman</td><td/></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>03/07/2024</td><td>Dana Mehra</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Syncope, unspecified syncope type R55 ; Hyperlipidemia, unspecified E78.5 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Anxiety disorder, unspecified F41.9 ; Benign prostatic hyperplasia with lower urinary tract symptoms N40.1 and Parkinson's disease, unspecified whether dyskinesia present, unspecified whether manifestations fluctuate G20.A1</td></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>04/18/2024</td><td>Dana Mehra</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Annual physical exam Z00.00 ; Hyperlipidemia, unspecified E78.5 ; Anxiety disorder, unspecified F41.9 ; Benign prostatic hyperplasia with lower urinary tract symptoms N40.1 ; Chronic sore throat J31.2 ; BMI 25.0-25.9,adult Z68.25 and Myalgia M79.10</td></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>350 N PINE ISLAND RD STE 302 PLANTATION, FL 33324-1849</td><td>07/25/2024</td><td>Jarrod Frydman</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Hyperlipidemia, unspecified E78.5 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Benign prostatic hyperplasia with lower urinary tract symptoms N40.1 ; Anxiety disorder, unspecified F41.9 ; Overactive bladder N32.81 ; Parkinson's disease without dyskinesia, with fluctuating manifestations G20.A2 ; Gastro-esophageal reflux disease without esophagitis K21.9 ; Nonrheumatic aortic (valve) insufficiency I35.1 ; Allergic rhinitis due to pollen J30.1 and BMI 25.0-25.9,adult Z68.25</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">03/07/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>DASH DIET. MAINTAIN BP LESS THAN 145/85.</td><td/><td/></tr><tr><td ID="ref2">03/07/2024</td><td>Syncope, unspecified syncope type (ICD-10 - R55)</td><td/><td><p>S/P CARDIO EVAL- ECHO ORDERED</p><p>WILL ORDER</p><p>CT BRAIN W/O CONTRAST STAT</p><p>CAROTID US </p><p>INCREASE HYDRATION</p><p>CALL OFFICE IF ANY FURTHER EPISODES. </p></td><td/></tr><tr><td ID="ref3">04/18/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>DASH DIET. MAINTAIN BP LESS THAN 145/85.</td><td/><td/></tr><tr><td ID="ref4">04/18/2024</td><td>Annual physical exam (ICD-10 - Z00.00)</td><td/><td><p>Check fasting labs. Annual eye exam and dental exams. </p><p>Increase formal exercise. Heart healthy diet. </p><p>Advanced directives and living will discussed. </p><p>Annual PSA testing. </p><p>Colon CA screening age 45 with future recommendations as per GI. </p><p>Recommend annual flu vaccines. </p><p>Recommend COVID 19 vaccines</p><p>Corona virus precaution discussed.</p></td><td/></tr><tr><td ID="ref5">07/25/2024</td><td>Hyperlipidemia, unspecified (ICD-10 - E78.5)</td><td>CHANGE ATORVASTATIN----------&gt;  ROSUVASTATIN 5 MG QHS, 2/2 MYALGIAS.   STOP FISH OIL.   LOW CHOL AND FAT DIET.  GOAL LDL &lt;130.</td><td/><td/></tr><tr><td ID="ref6">07/25/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>DASH DIET. MAINTAIN BP LESS THAN 145/85.</td><td/><td/></tr><tr><td ID="ref7">07/25/2024</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td>AVOID NEPHROTOXINS. MAINTAIN ADEQUATE HYDRATION</td><td/><td/></tr><tr><td ID="ref8">04/18/2024</td><td>Hyperlipidemia, unspecified (ICD-10 - E78.5)</td><td>LOW CHOL AND FAT DIET.</td><td>DECREASE STATIN 1/2 TAB DAILY</td><td/></tr><tr><td ID="ref9">03/07/2024</td><td>Hyperlipidemia, unspecified (ICD-10 - E78.5)</td><td>LOW CHOL AND FAT DIET.</td><td/><td/></tr><tr><td ID="ref10">03/07/2024</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td>AVOID NEPHROTOXINS. MAINTAIN ADEQUATE HYDRATION</td><td/><td/></tr><tr><td ID="ref11">04/18/2024</td><td>Anxiety disorder, unspecified (ICD-10 - F41.9)</td><td>RELAXATION TECHNIQUES DISCUSSED. RARE USE OF XANAX PRN</td><td/><td/></tr><tr><td ID="ref12">07/25/2024</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms (ICD-10 - N40.1)</td><td>FOLLOWED BY URO DR. MARKS. BENIGN BREAST BIOPSY --11/2020</td><td/><td/></tr><tr><td ID="ref13">07/25/2024</td><td>Anxiety disorder, unspecified (ICD-10 - F41.9)</td><td>RELAXATION TECHNIQUES DISCUSSED. RARE USE OF XANAX PRN</td><td/><td/></tr><tr><td ID="ref14">04/18/2024</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms (ICD-10 - N40.1)</td><td>FOLLOWED BY URO DR. MARKS. BENIGN BREAST BIOPSY --11/2020</td><td/><td/></tr><tr><td ID="ref15">03/07/2024</td><td>Anxiety disorder, unspecified (ICD-10 - F41.9)</td><td>RELAXATION TECHNIQUES DISCUSSED. RARE USE OF XANAX PRN</td><td/><td/></tr><tr><td ID="ref16">03/07/2024</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms (ICD-10 - N40.1)</td><td>FOLLOWED BY URO DR. MARKS. BENIGN BREAST BIOPSY --11/2020</td><td/><td/></tr><tr><td ID="ref17">04/18/2024</td><td>Chronic sore throat (ICD-10 - J31.2)</td><td/><td><p>S/P PPI, </p><p>ENT EVAL--&gt;REC GI EVAL</p></td><td/></tr><tr><td ID="ref18">07/25/2024</td><td>Overactive bladder (ICD-10 - N32.81)</td><td>SEEN BY URO DR. MARKS. DECLINES MEDS</td><td/><td/></tr><tr><td ID="ref19">07/25/2024</td><td>Parkinson's disease without dyskinesia, with fluctuating manifestations (ICD-10 - G20.A2)</td><td>S/P NEURO EVAL.  CONT SIMEMET BID.   REGULAR EXERCISE.  FALL PRECAUTIONS.</td><td/><td/></tr><tr><td ID="ref20">04/18/2024</td><td>BMI 25.0-25.9,adult (ICD-10 - Z68.25)</td><td/><td/><td/></tr><tr><td ID="ref21">03/07/2024</td><td>Parkinson's disease, unspecified whether dyskinesia present, unspecified whether manifestations fluctuate (ICD-10 - G20.A1)</td><td/><td/><td/></tr><tr><td ID="ref22">07/25/2024</td><td>Gastro-esophageal reflux disease without esophagitis (ICD-10 - K21.9)</td><td>GERD DIET. OMEPRAZOLE PRN</td><td/><td/></tr><tr><td ID="ref23">07/25/2024</td><td>Nonrheumatic aortic (valve) insufficiency (ICD-10 - I35.1)</td><td>MONITORED BY DR. CUSNIR- CARDIO</td><td/><td/></tr><tr><td ID="ref24">04/18/2024</td><td>Myalgia (ICD-10 - M79.10)</td><td/><td/><td/></tr><tr><td ID="ref25">07/25/2024</td><td>Allergic rhinitis due to pollen (ICD-10 - J30.1)</td><td>CONT MONTELUKAST DAILY.    FLONASE AND LORATIDINE DAILY PRN.</td><td/><td/></tr><tr><td ID="ref26">07/25/2024</td><td>BMI 25.0-25.9,adult (ICD-10 - Z68.25)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">HEDIS: Blood Pressure Diastolic Less than 80</td><td>07/25/2024</td></tr><tr><td ID="pendingTest2">HEDIS: Blood Pressure Diastolic Less than 80</td><td>04/18/2024</td></tr><tr><td ID="pendingTest3">HEDIS: Blood Pressure Systolic &lt; 130</td><td>07/25/2024</td></tr><tr><td ID="pendingTest4">HEDIS: Blood Pressure Systolic &lt; 130</td><td>04/18/2024</td></tr><tr><td ID="pendingTest5">HEDIS: COA Functional Status</td><td>04/18/2024</td></tr><tr><td ID="pendingTest6">HEDIS: COA Medication Review</td><td>04/18/2024</td></tr><tr><td ID="pendingTest7">HEDIS: COA Medication Review</td><td>07/25/2024</td></tr><tr><td ID="pendingTest8">HEDIS: COA Pain Not Present</td><td>04/18/2024</td></tr><tr><td ID="pendingTest9">HEDIS: Depression Screening (If completed)</td><td>04/18/2024</td></tr><tr><td ID="pendingTest10">HEDIS: Fall Risk (If completed)</td><td>04/18/2024</td></tr><tr><td ID="pendingTest11">HEDIS: Tobacco Non-User</td><td>07/25/2024</td></tr><tr><td ID="pendingTest12">HEDIS: Tobacco Non-User</td><td>04/18/2024</td></tr><tr><td ID="pendingTest13">HEDIS: Advanced Care Planning</td><td>04/18/2024</td></tr><tr><td ID="pendingTest14">HEDIS: BMI 22 - 30</td><td>04/18/2024</td></tr><tr><td ID="pendingTest15">HEDIS: BMI 22 - 30</td><td>07/25/2024</td></tr><tr><td ID="pendingTest16">HEDIS: Depression Screening - Negative</td><td>04/18/2024</td></tr><tr><td ID="pendingTest17">HEDIS: Fall Risk - No Falls or 1 fall</td><td>04/18/2024</td></tr><tr><td ID="pendingTest18">HEDIS: COA Medication Review</td><td>04/07/2023</td></tr><tr><td ID="pendingTest19">HEDIS: Tobacco Non-User</td><td>04/07/2023</td></tr><tr><td ID="pendingTest20">HEDIS: BMI 22 - 30</td><td>04/07/2023</td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">LIPID PANEL WITH RATIOS (19543)</td><td>07/25/2024</td></tr><tr><td ID="futureTest2">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>07/25/2024</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:Jarrod Frydman, 11/25/2024 08:30:00 AM, 350 N PINE ISLAND RD, STE 302, PLANTATION, FL, 33324-1849, 954-581-8272</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Preferred Care Partners</td><td>PO BOX 30448 SALT LAKE CITY, UT 84130-0745</td><td>305-670-8444</td><td>949388629</td><td>78601</td><td>CIANCI, HUMBERTO</td><td>Self - patient is the insured</td><td/><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>GAD</td><td/></tr><tr><td>benign prostatic hypertrophy</td><td/></tr><tr><td>hyperlipidemia</td><td/></tr><tr><td>Hypertension</td><td/></tr><tr><td>vertigo</td><td/></tr><tr><td>renal cysts: Right</td><td/></tr><tr><td>Nephrolithiasis: B/L</td><td/></tr><tr><td>rhinitis: allergic</td><td/></tr><tr><td>aortic insufficiency: moderate</td><td/></tr><tr><td>Rt hip bone cyst</td><td/></tr><tr><td>fracture left hemisacrum oblique</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>Knee Surgery B/L</td><td/></tr><tr><td>umbilical hernia</td><td/></tr><tr><td>Cholecystectomy</td><td/></tr><tr><td>pterygium</td><td/></tr><tr><td>prostate biopsy, benign</td><td>11/20</td></tr></tbody></table></div><br/><br/></body></html>